Celltrion Pharm, Inc. clinical trials
Acquired by Celltrion, 2014 · source ↗
The registry lists 4 studies whose lead sponsor is Celltrion Pharm, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 8, 2026.
Before and after it joined Celltrion
- First submitted before Celltrion Pharm, Inc. became part of Celltrion
- 0
- First submitted after Celltrion Pharm, Inc. became part of Celltrion
- 4
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Celltrion Pharm, Inc.4 studies
Something wrong with this grouping? Tell us on the Celltrion page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All Celltrion studies →
- Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High CholesterolCompletedNCT07564726Phase 3
Sponsor listed in the registry: Celltrion Pharm, Inc. · First submitted after Celltrion Pharm, Inc. became part of Celltrion
- A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin TherapyCompletedNCT03499704Phase 4
Sponsor listed in the registry: Celltrion Pharm, Inc. · First submitted after Celltrion Pharm, Inc. became part of Celltrion
- A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South KoreaCompletedNCT04470830
Sponsor listed in the registry: Celltrion Pharm, Inc. · First submitted after Celltrion Pharm, Inc. became part of Celltrion
- A Study for PMS of AZL-M in the Treatment of Adult Participants With Essential Hypertension in South KoreaCompletedNCT04470817
Sponsor listed in the registry: Celltrion Pharm, Inc. · First submitted after Celltrion Pharm, Inc. became part of Celltrion